We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...
The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...
The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...
The Biden-era law is now in the hands of a new administration, and drugmakers are scanning the horizon for hints of a massive ...
The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic and Wegovy.
She learned that she would have to try, and "fail," on two other drugs before Medicare would cover the new one.
CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the ...
If big pharma was hoping that there would not be drug price negotiations under President Trump, they seem to have had their hopes dashed. That ...
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...
Explore how Medicare drug price negotiations under the Inflation Reduction Act could evolve with the Trump administration.
Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...